| Powder: | Yes |
|---|---|
| Customized: | Customized |
| Certification: | GMP, HSE, ISO 9001, USP, BP |
| Suitable for: | Elderly, Children, Adult |
| State: | White Powder |
| Purity: | >99% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier
| Items Tested | Specification | Result |
| Description | White or almost crystalline white powder | White crystalline powder |
| Identification | IR & UV & TLC | Confirm |
| Melting point | 230°C ~ 240 °C | 234.6 °C ~ 235.4 °C |
| Loss on drying | ≤ 0.5 % | 0.28% |
| PH | 4.0 ~ 6.0 | 5.6 |
| Residue on Ignition | ≤ 0.5% | 0.33% |
| Ash | ≤ 0.2% | 0.05% |
| Related substance | ≤ 1.0 % | 0.1 % |
| Heavy metals | ≤ 10 ppm | 0.8ppm |
| Total impurities | ≤ 1.0 % | 0.37% |
| Single impurities | ≤ 0.5% | 0.28% |
| Assay | 99.0-102% | 99.5% |
Rimonabant selectively blocks the CB1 receptors that are present in the brain and other peripheral organs important in fat/lipid and glucose metabolism, including muscle, gastrointestinal tract, liver and adipose tissue. Basically, it switches off those brain circuits that are responsible for making people hungry while smoking. Acomplia, along with CB1 receptors, reduces the EC system's over-activity.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}